Precept Management’s Novo Nordisk NVO Stock Holding History

Precept Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52,000	Closed	-$1.4M	–	81
2017 Q4	$1.4M	Buy	+52,000	New	+$1.32M	0.83%	33

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Precept Management's NVO Position: Q1 2018 in Review

Precept Management sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 52,000 shares — an estimated $1.4M sold.

Precept Management first reported a position in NVO in Q4 2017 and held it in 1 quarter. The position peaked at $1.4M in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

Precept Management reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
Precept Management sold 52,000 Novo Nordisk shares in Q1 2018, an estimated $1.4M.
Precept Management first reported a position in Novo Nordisk in Q4 2017 and held it in 1 quarter.
Precept Management's Novo Nordisk position peaked at $1.4M in Q4 2017.
553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Precept Management's 13F filing for Q1 2018, filed 15 May 2018.